Exisulind

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Exisulind
Exisulind.png
Names
IUPAC name
2-[(1Z)-5-fluoro-1-[(4-methanesulfonylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid
Identifiers
ChEBI CHEBI:64212
ChemSpider 4582441
Jmol-3D images Image
PubChem 5472495
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Exisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Trademark by OSI Pharmaceuticals is Aptosyn. NCBI PubChem ID 5472495. Also listed as Sulindac sulfone which is a metabolic product of Sulindac (see).